Epizyme Inc (NASDAQ:EPZM)

17.35
Delayed Data
As of Feb 21
 -0.45 / -2.53%
Today’s Change
9.30
Today|||52-Week Range
20.45
+38.25%
Year-to-Date
No recent news for Epizyme Inc.

Today’s Trading

Previous close17.80
Today’s open17.85
Day’s range17.30 - 18.25
Volume319,752
Average volume (3 months)480,435
Market cap$1.2B
Data as of 4:00pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)+41.87%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+212.77%
P/E ratioNM
Price/Sales86.33
Price/Book5.12

Competitors

----
FPRXFive Prime Therapeut...-1.21-6.41%
RTRXRetrophin Inc-0.06-0.26%
SGMOSangamo Therapeutics...-0.05-0.22%
Data as of 4:00pm ET, 02/21/2018

Financials

Next reporting dateMarch 8, 2018
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$8.0M
Annual profit (last year)-$110.2M
Net profit margin-1,376.45%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary &
Director
Robert B. Bazemore
Chief Operating Officer
Matthew E. Ros
Corporate headquarters
Cambridge, Massachusetts

Forecasts